SCHEMBL21865072

SCHEMBL21865072

Fc1c(N2CCOCC2)ccc2cc(Br)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.43
CCR5 P51681 1/20 0.43
MAPT P10636 6/20 0.43
KMT2A Q03164 2/20 0.43
RXFP1 Q9HBX9 2/20 0.43
SLC6A5 Q9Y345 1/20 0.41
MAPK1 P28482 2/20 0.40
PRKDC P78527 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TLR9 Q9NR96 1/20 0.39
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21865069 0.82 TSHR (0.46) MAPTKMT2AMAPK1PRKDCSMN1; SMN2
SCHEMBL3122343 0.78 SLC6A5 (0.55) CCR5MAPTKMT2ASLC6A5MAPK1
SCHEMBL29508149 0.78 SLC6A5 (0.55) CCR5MAPTKMT2ASLC6A5MAPK1
SCHEMBL23336133 0.75 KMT2A (0.45) MAPTKMT2ARXFP1SLC6A5SMN1; SMN2
SCHEMBL2795825 0.74 CCR5 (0.52) BACE1CCR5MAPTSLC6A5MAPK1
SCHEMBL17579481 0.73 HTT (0.50) CCR5MAPTRXFP1MAPK1SMN1; SMN2
SCHEMBL29173402 0.73 MAPT (0.50) MAPTKMT2AMAPK1SMN1; SMN2GAA
SCHEMBL13718469 0.73 MAPT (0.64) BACE1CCR5MAPTKMT2AMAPK1
SCHEMBL29173362 0.72 CCR5 (0.47) BACE1CCR5MAPTKMT2ASLC6A5
SCHEMBL2711594 0.71 KDM4E (0.59) BACE1CCR5MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063854-A1 QUINOLINE-BASED DERIVATIVES AS VAP-1 INHIBITORS 南京明德新药研发有限公司 2020-04-02 WO disclosed